Fabrication of Mebendazole Loaded Solid Lipid Nanoparticles: Formulation, Optimization, Characterization, Stabilization, and In-Vitro Evaluation
Abstract
The research focused on the formulation, optimization, characterization stabilization and in vitro evaluation of Mebendazole loaded solid lipid nanoparticles (MEB-SLN) using response surface methodology. MEB-SLN was developed using the melt-emulsification ultrasonication method. The optimized formulation contains Compritol 888 ATO as a solid lipid and Poloxamer 407 as a surfactant. The optimized MEB-SLN was spherical, and had an average size of 230.4nm, and zeta potential of -21.9mV. The physiochemical characterization included the evaluation of surface morphology, drug entrapment, x-ray diffraction studies, and differential scanning calorimetry. In vitro drug release studies revealed that MEB-SLN would release drugs for up to 24 hrs. The formulation was found to be significantly quite stable in the refrigerator than at room temperature, as per stability tests. As a result of these findings, MEB-SLN was identified as a possible drug carrier. This provides a framework for further exploration of the developed formulation.
Keywords:
Mebendazole, Solid lipid nanoparticles, Box-behnken design, In vitro evaluation, Stability studies.DOI
https://doi.org/10.25004/IJPSDR.2022.140217References
Kumar S, Narayan R, Ahammed V, Nayak Y, Naha A, Nayak UY. Development of ritonavir solid lipid nanoparticles by Box Behnken design for intestinal lymphatic targeting. Journal of Drug Delivery Science and Technology. 2018;44:181-9. Available from: https://doi. org/10.1016/j.jddst.2017.12.014
Rehman MU, Khan MA, Khan WS, Shafique M, Khan M. Fabrication of Niclosamide loaded solid lipid nanoparticles: in vitro characterization and comparative in vivo evaluation. Artificial cells, nanomedicine, and biotechnology. 2018;46(8):1926-34. Available from: https:// doi.org/10.1080/21691401.2017.1396996
Battaglia L, Ugazio E. Lipid nano-and microparticles: an overview of patent-related research. Journal of Nanomaterials. 2019;1-23. Available from: https://doi.org/10.1155/2019/2834941
Saneja A, Panda AK, Lichtfouse E. Sustainable Agriculture Reviews 43: Pharmaceutical Technology for Natural Products Delivery, Vol. 1 Springer Nature, Switzerland Fundamentals and Applications, 2020, 67-112. Available from: ISBN: 3030418383, 9783030418380
Velmurugan R, Selvamuthukumar S. Development and optimization of ifosfamide nanostructured lipid carriers for oral delivery using response surface methodology. Applied nanoscience. 2016;6(2):159- 73. Available from: https://doi.org/10.1007/s13204-015-0434-6
Makwana V, Jain R, Patel K, Nivsarkar M, Joshi A. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. International journal of pharmaceutics. 2015;495(1):439-46. Available from: https://doi.org/10.1016/j. ijpharm.2015.09.014
Shrivastava S, Kaur CD. Perception of lymphatic system and their disorders. British Journal of Pharmaceutical and Medical Research. 2018; 3(4):1119-31. Available from: 10.24942/bjpmr.2018.289
Shrivastava S, Gupta A, Kaur CD. The Epitome of Novel Techniques and Targeting Approaches in Drug Delivery for Treating Lymphatic Filariasis. Current Drug Targets. 2020;21(12):1250-63. Available from: https://doi.org/10.2174/1389450121666200630111250
Shrivastava S, Gidwani B, Gupta A, Kaur CD. Ethnopharmacological approaches to treat lymphatic filariasis. International Journal of Pharmacy and Analytical Research. 2016;5(3):445-70.
Shrivastava S, Shrivastava S, Tiwle R. Validation of novel UV Spectrophotometric method for the determination of Ketoconazole in Pharmaceutical Formulation. J Pharm Adv Res. 2020; 3(2):792-8.
Parmar L, Gupta M, Parkhe G. Formulation, characterization and in vitro evaluation of floating microspheres of mebendazole as a gastro retentive dosage form. Journal of Drug Delivery and Therapeutics. 2018;8(5-s):311-4. Available from: https://doi.org/10.22270/jddt. v8i5-s.1980
Sandulovici R, Mircioiu C, Voicu V, Ghafil F, Mati E, Anuta V, Sarbu I, Mircioiu I. Modelling of release kinetics of mebendazole from solid dispersion based formulations in simulted gastric fluid. Rom. Biotechnol. L ett. 2 020;25:1473-81. A vailable f rom: 1 0.25083/ rbl/25.2/1473.1481
Parakh DR, Patil MP, Dashputre NL, Kshirsagar SJ. Development of self-microemulsifying drug delivery system of mebendazole by spray drying technology: characterization, in vitro and in vivo evaluation. Drying Technology. 2016;34(9):1023-42. Available from: https://doi.org/10.1080/07373937.2015.1090447
Rao MR, Raut SP, Shirsath CT, Jadhav MB. Self-nanoemulsifying drug delivery system of mebendazole for treatment of lymphatic filariasis. Indian Journal of Pharmaceutical Sciences. 2018;80(6):1057-68. Available from: 10.4172/pharmaceutical-sciences.1000456
Tavakoli F, Shafiee H, Ghasemikhah R. Application of guar gum in electrospun nanofibers as mebendazole drug release controller: a kinetic study and thermodynamics analysis. Quarterly Journal of Iranian Chemical Communication. 2020;8(1):92-101. Available from: https://dx.doi.org/10.30473/icc.2020.50066.1640
Graves RA, Ledet GA, Nation CA, Pramar YV, Bostanian LA, Mandal TK. Effect of squalane on mebendazole-loaded Compritol® nanoparticles. Journal of Biomaterials Science, Polymer Edition. 2015;26(13):868-80. Available from: https://doi.org/10.1080/09 205063.2015.1061351
Shrivastava S, Gidwani B, Kaur CD. Development of mebendazole loaded nanostructured lipid carriers for lymphatic targeting: Optimization, characterization, in-vitro and in-vivo evaluation. Particulate Science and Technology. 2021;39(3):380-90. Available from: https://doi.org/10.1080/02726351.2020.1750515
Jari SD, Yousif JJ. Therapeutic effects of silver nanoparticles loaded with albendazole, mebendazole drugs in male albino mice infected with hydatid cysts. International Research Journal of Advanced Science. 2020;1(1):13-8.
Gidwani B, Vyas A, Kaur CD. Cytotoxicity and pharmacokinetics study of nanostructured lipid carriers of mechlorethamine: Preparation, optimization and characterization. Particulate Science and Technology. 2020; 38(1):23-33. Available from: https://doi.org /10.1080/02726351.2018.1536685
Pradhan M, Singh D, Singh MR. Fabrication, optimization and characterization of Triamcinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis: Application of Box Behnken design, in vitro and ex vivo studies. Journal of drug delivery science and technology. 2017;41:325-33. Available from: https:// doi.org/10.1016/j.jddst.2017.07.024
Qumber M, Alruwaili NK, Bukhari SN, Alharbi KS, Imam SS, Afzal M, Alsuwayt B, Mujtaba A, Ali A. BBD-based development of itraconazole loaded nanostructured lipid carrier for topical delivery: in vitro evaluation and antimicrobial assessment. Journal of p harmaceutical i nnovation. 2 02;16(1):85-98. A vailable f rom: https://doi.org/10.1007/s12247-019-09420-5
Gidwani B, Vyas A. Preparation, characterization, and optimization of altretamine-loaded solid lipid nanoparticles using Box-Behnken design a nd r esponse s urface m ethodolog y. A rtificial c ells, nanomedicine, and biotechnology. 2016;44(2):571-80. Available from: https://doi.org/10.3109/21691401.2014.971462
Gidwani B, Vyas A. Formulation, characterization and evaluation of cyclodextrin-complexed bendamustine-encapsulated PLGA nanospheres for sust ained deliver y in cancer t reatment . Pharmaceutical Development and Technology. 2016;21(2):161-71. Available from: https://doi.org/10.3109/10837450.2014.979945
Moghddam SM, Ahad A, Aqil M, Imam SS, Sultana Y. Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box–Behnken design approach. Artificial cells, nanomedicine, and biotechnology. 2017;45(3):617-24. Available from: https://doi. org/10.3109/21691401.2016.1167699
Soni K, Rizwanullah M, Kohli K. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box- Behnken design for improved oral efficacy against cancer: In vitro, ex vivo and in vivo assessments. Artificial cells, nanomedicine, and biotechnology. 2018;46(sup1):15-31. Available from: https://doi. org/10.1080/21691401.2017.1408124
Jazuli I, Nabi B, A lam T, Baboot a S, A li J. Optimization of nanostructured lipid carriers of lurasidone hydrochloride using Box-Behnken design for brain targeting: in vitro and in vivo studies. Journal of Pharmaceutical Sciences. 2019;108(9):3082-90. Available from: https://doi.org/10.1016/j.xphs.2019.05.001
Alcantara KP, Zulfakar MH, Castillo AL. Development, characterization and pharmacokinetics of mupirocin-loaded nanostructured lipid carriers (NLCs) for intravascular administration. International journal of Pharmaceutics. 2019 ;571:118705. Available from: https://doi.org/10.1016/j.ijpharm.2019.118705
Ijaz M, A k ht ar N. Fat t y acids based α‐Tocopherol loaded nanostructured lipid carrier gel: In vitro and in vivo evaluation for moisturizing and anti‐aging effects. Journal of Cosmetic Dermatology. 2020;19(11):3067-76. Available from: https://doi. org/10.1111/jocd.13346
Rapalli VK, Kaul V, Waghule T, Gorantla S, Sharma S, Roy A, Dubey SK, Singhvi G. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition. European Journal of Pharmaceutical Sciences. 2020;152:105438. Available from: https://doi.org/10.1016/j.ejps.2020.105438
Teng Z, Yu M, Ding Y, Zhang H, Shen Y, Jiang M, Liu P, Opoku-Damoah Y, Webster TJ, Zhou J. Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability. International Journal of Nanomedicine. 2019;14:119. Available from: https://dx.doi.org/10.2147%2FIJN.S186899
Published
Abstract Display: 653 
PDF Downloads: 507 
